MLSSNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
MILESTONE SCIENTIFIC INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33+0.01 (+1.99%)
Close on Oct 19, 2026
- Market cap
- $31.01M
- P/E (TTM)
- –
- Dividend yield
- –
Milestone Scientific statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Orthopedic, Prosthetic & Surgical Appliances & Supplies companies for comparison
Valuation
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Market Cap | $29.55M | $230.55M |
| Enterprise Value | $27.48M | $202.97M |
| PS Ratio | 3.14 | 3.10 |
| PB Ratio | 8.51 | 3.04 |
| P/TBV Ratio | 8.63 | 4.43 |
Enterprise value
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| EV / Sales | 2.92 | 2.91 |
Income (trailing twelve months)
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Revenue | $9.42M | $102.39M |
| Gross Profit | $6.62M | $60.36M |
| Operating Income | -$4.10M | -$4.31M |
| Pretax Income | -$4.14M | -$2.37M |
| Net Income | -$4.14M | -$6.57M |
| EBITDA | -$4.03M | -$1.98M |
| EPS (Diluted) | -$0.04 | -$0.08 |
Margins
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Gross Margin | 70.2% | 55.2% |
| Operating Margin | -43.6% | -6.04% |
| Pretax Margin | -44.0% | -4.11% |
| Profit Margin | -44.0% | -10.5% |
| EBITDA Margin | -42.7% | -2.67% |
| FCF Margin | -6.98% | 0.02% |
Returns
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Return on Equity (ROE) | -121.7% | -18.2% |
| Return on Assets (ROA) | -50.5% | -13.3% |
| Return on Invested Capital (ROIC) | -151.8% | -3.69% |
| Return on Capital Employed (ROCE) | -103.9% | -9.07% |
Growth
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 3.72% | 8.85% |
| Revenue Growth (3Y CAGR) | 0.63% | 7.08% |
| Revenue Growth (5Y CAGR) | 10.5% | 11.8% |
Balance sheet
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.07M | $36.66M |
| Net Cash (Debt) | $2.07M | $3.92M |
| Net Cash Per Share | $0.02 | $0.28 |
| Equity (Book Value) | $3.47M | $55.33M |
| Book Value Per Share | $0.04 | $2.87 |
| Tangible Book Value | $3.43M | $10.79M |
| Working Capital | $3.72M | $56.72M |
Financial position
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Current Ratio | 1.85 | 2.48 |
| Quick Ratio | 0.47 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Operating Cash Flow | -$642.64K | -$566.22K |
| Capital Expenditures | -$15.12K | -$3.69M |
| Free Cash Flow | -$657.76K | -$696.00K |
| FCF Per Share | -$0.01 | -$0.02 |
Efficiency
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Asset Turnover | 1.15 | 0.58 |
| Inventory Turnover | 0.80 | 2.21 |
| Revenue Per Employee | $628.08K | $322.92K |
| Profits Per Employee | -$276.25K | -$51.88K |
| Employee Count | 15 | 185 |
Dividends and yields
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Earnings Yield | -14.0% | -6.88% |
| FCF Yield | -2.23% | -0.45% |
Shares
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Shares Outstanding | 88,739,200 | 44,302,700 |
| Shares Change (YoY) | 6.26% | 3.36% |
| Shares Change (QoQ) | 10.3% | 0.27% |
| Float | 60,539,400 | 37,462,700 |
| Shares Held by Insiders | 31.8% | 10.5% |
| Shares Held by Institutions | 5.30% | 63.5% |
Scores
| Measure | Milestone Scientific | Industry median |
|---|---|---|
| Altman Z-Score | -19.08 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Milestone Scientific's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.